Clinical Trial: A Single-arm, Phase II, Multi-center Clinical Trial of Sintilimab During the Perioperative Period in Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

U.S., Jan. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07379424) titled 'A Single-arm, Phase II, Multi-center Clinical Trial of Sintilimab During the Perioperative Period in Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma' on Aug. 04, 2025.

Brief Summary: This study is a single-arm, multi-center Phase II clinical trial. As depicted in the following study design diagram, its objective is to observe and assess the efficacy and safety of sintilimab during the perioperative period in patients with resectable locally advanced head and neck squamous cell carcinoma.

Study Start Date: Jan. 28

Study Type: INTERVENTIONAL

Condition: Resectable Locally Advanced Head and Neck Squam...